abstract |
The invention relates to cross-beta structures and the biological role of these cross-beta structures. Methods for modulating extracellular protein degradation and/or protein clearance by dialysis or for diminishing plaques involved in conformational diseases by modulating cross-beta structure formation and/or tissue plasminogen activator (tPA)-like activity are disclosed, as well as diagnostic methods by visualising cross-beta structures. |